Viking Global Investors
Viking Global Investors is a long/short equity hedge fund. The fund employs a bottom-up fundamental stock-picking strategy for its investments in equities in the U.S. and Europe. It focuses on the financial, telecommunication, media, technology, and consumer sectors. Viking Global Investors is based in New York and was founded in October, 1999 by Andreas Halvorsen, David Ott, and Brian Olson.
Messers. Halvorsen, Ott, and Olson worked together at Tiger Management Corp. All three left Tiger in early 1999.
View Older Stories View More Recent Stories
-
Cazoo (CZOO) Announces Conclusion of Strategic Review of its EU Business, to Commence Orderly Wind Down
-
Cazoo Announces Conclusion of Strategic Review of its EU Business
-
Patina Names Reed V. Tuckson, M.D., FACP, to Clinical Advisory Board
-
Impossible Foods Introduces Impossible™ Bowls — New Plant-Based Meals in the Frozen Aisle
-
Whole Earth Brands, Inc. Appoints Michael Franklin to its Board of Directors
-
Ayana Bio Announces Appointment of Frank Jaksch as Chief Executive Officer
-
Billionaire hedge fund manager Julian Robertson dies at 90- spokesman
-
Mythic Therapeutics Announces Appointment of Gilles Gallant, BPharm PhD FOPQ as Chief Development Officer
-
Form 13F-HR VIKING GLOBAL INVESTORS For: Jun 30
-
Standard BioTools Announces Second Quarter 2022 Financial Results and Provides Strategic Update
-
Cazoo Announces Second Quarter and First Half 2022 Financial Results
-
Cazoo to Announce Second Quarter and First Half 2022 Results on August 2, 2022
-
Best Stocks Under $5 On Robinhood? 4 To Watch Before Next Week
-
Form 6B ORDR Viking Global Equities
-
Sampled Appoints Sarah Hersey, VP, Head of Translational Sciences & Diagnostics at Bristol Myers Squibb, as its First Independent Director
-
Form SC 13G Ginkgo Bioworks Holdings Filed by: VIKING GLOBAL INVESTORS LP
-
AlphaSense's Valuation Jumps to $1.7 Billion with $225 Million Series D Led by Goldman Sachs Asset Management and Viking Global
-
Form 6B NTC Viking Global Equities
-
Global Processing Services names Cameron Cox as Chief Transformation Officer
-
Form SC 13G Celldex Therapeutics, Filed by: VIKING GLOBAL INVESTORS LP
-
Cazoo (CZOO) Announces Business Realignment Plan
-
Cazoo Announces Business Realignment Plan
-
Form 40-6B/A VIKING GLOBAL INVESTORS
-
Global Processing Services Names Jill Docherty as Director, Global Partnerships
-
Form SC 13G PepGen Inc. Filed by: VIKING GLOBAL INVESTORS LP
-
Impossible Foods Launches in the United Kingdom
-
Locus Biosciences Announces $35 Million Financing
-
Locus Biosciences Announces $35 Million Financing
-
Form 13F-HR VIKING GLOBAL INVESTORS For: Mar 31
-
Form 13F-HR/A VIKING GLOBAL INVESTORS For: Sep 30
-
Form 13F-HR/A VIKING GLOBAL INVESTORS For: Dec 31
-
Dock Raises $110 Million, Bringing Total Valuation to Over $1.5 Billion
-
Standard BioTools Announces First Quarter 2022 Financial Results
-
Global Processing Services names Simon Stanford as Chief Revenue Officer
-
Cazoo Announces First Quarter 2022 Financial Results
-
Chimera Appoints New CEO, Wins AFCR BRACE Award, and Accelerates towards the Clinic with TME-Modifying CAR-T Therapies for Solid Tumors
-
Form SC 13G STANDARD BIOTOOLS INC. Filed by: VIKING GLOBAL INVESTORS LP
-
Ginkgo Bioworks (DNA) and Elanco (ELAN) Launch BiomEdit
-
Elanco and Ginkgo Bioworks Launch BiomEdit, a New Animal Health Company Leveraging Microbiome Technology
-
Cazoo Announces Fourth Quarter and Full Year 2021 Financial Results
-
Horizon Technology Finance Leads $15 Million Venture Loan to MyForest Foods
-
Fluidigm (FLDM) Completes $250 Million Strategic Capital Infusion and Changes Name to Standard BioTools Inc.
-
Fluidigm Completes $250 Million Strategic Capital Infusion and Changes Name to Standard BioTools Inc.
-
Fluidigm (FLDM) Announces Stockholders Approve $250 Million Strategic Capital Infusion
-
Fluidigm Stockholders Approve $250 Million Strategic Capital Infusion
-
Fluidigm (FLDM) Announces Support Agreement with Caligan Partners Related to $250 Million Strategic Capital Infusion by Casdin Capital and Viking Global
-
Fluidigm Announces Support Agreement with Caligan Partners Related to $250 Million Strategic Capital Infusion by Casdin Capital and Viking Global
-
Fluidigm (FLDM) Highlights the Strategic Capital Infusion by Casdin Capital and Viking Global as the Only Actionable Financing Solution
-
Fluidigm Highlights the Strategic Capital Infusion by Casdin Capital and Viking Global as the Only Actionable Financing Solution
-
Fluidigm Adjourns Special Meeting of Stockholders Until April 1, 2022
